nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitomycin—Alkylating Activity—Melphalan—peripheral nervous system neoplasm	0.346	0.556	CiPCiCtD
Mitomycin—Alkylating Activity—Dacarbazine—peripheral nervous system neoplasm	0.276	0.444	CiPCiCtD
Mitomycin—ABCB1—peripheral nervous system neoplasm	0.16	1	CbGaD
Mitomycin—POR—Doxorubicin—peripheral nervous system neoplasm	0.0778	0.494	CbGbCtD
Mitomycin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0191	0.121	CbGbCtD
Mitomycin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0191	0.121	CbGbCtD
Mitomycin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0132	0.084	CbGbCtD
Mitomycin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00815	0.0517	CbGbCtD
Mitomycin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0076	0.0482	CbGbCtD
Mitomycin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00747	0.0474	CbGbCtD
Mitomycin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00509	0.0323	CbGbCtD
Mitomycin—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00171	CcSEcCtD
Mitomycin—Alopecia—Vincristine—peripheral nervous system neoplasm	0.000104	0.00171	CcSEcCtD
Mitomycin—Stomatitis—Etoposide—peripheral nervous system neoplasm	0.000103	0.0017	CcSEcCtD
Mitomycin—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.000103	0.0017	CcSEcCtD
Mitomycin—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000103	0.00169	CcSEcCtD
Mitomycin—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.000102	0.00169	CcSEcCtD
Mitomycin—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000102	0.00168	CcSEcCtD
Mitomycin—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000102	0.00168	CcSEcCtD
Mitomycin—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000102	0.00167	CcSEcCtD
Mitomycin—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000102	0.00167	CcSEcCtD
Mitomycin—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000101	0.00165	CcSEcCtD
Mitomycin—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.0001	0.00165	CcSEcCtD
Mitomycin—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.0001	0.00165	CcSEcCtD
Mitomycin—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	9.93e-05	0.00163	CcSEcCtD
Mitomycin—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	9.93e-05	0.00163	CcSEcCtD
Mitomycin—Fatigue—Topotecan—peripheral nervous system neoplasm	9.93e-05	0.00163	CcSEcCtD
Mitomycin—Fatigue—Tretinoin—peripheral nervous system neoplasm	9.85e-05	0.00162	CcSEcCtD
Mitomycin—Fatigue—Isotretinoin—peripheral nervous system neoplasm	9.85e-05	0.00162	CcSEcCtD
Mitomycin—Pain—Topotecan—peripheral nervous system neoplasm	9.85e-05	0.00162	CcSEcCtD
Mitomycin—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	9.84e-05	0.00162	CcSEcCtD
Mitomycin—Anaemia—Alitretinoin—peripheral nervous system neoplasm	9.81e-05	0.00161	CcSEcCtD
Mitomycin—Decreased appetite—Melphalan—peripheral nervous system neoplasm	9.8e-05	0.00161	CcSEcCtD
Mitomycin—Pain—Tretinoin—peripheral nervous system neoplasm	9.77e-05	0.00161	CcSEcCtD
Mitomycin—Pain—Isotretinoin—peripheral nervous system neoplasm	9.77e-05	0.00161	CcSEcCtD
Mitomycin—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.00161	CcSEcCtD
Mitomycin—Fatigue—Melphalan—peripheral nervous system neoplasm	9.72e-05	0.0016	CcSEcCtD
Mitomycin—Pain—Melphalan—peripheral nervous system neoplasm	9.64e-05	0.00159	CcSEcCtD
Mitomycin—Discomfort—Dactinomycin—peripheral nervous system neoplasm	9.63e-05	0.00158	CcSEcCtD
Mitomycin—Malaise—Alitretinoin—peripheral nervous system neoplasm	9.57e-05	0.00157	CcSEcCtD
Mitomycin—Syncope—Alitretinoin—peripheral nervous system neoplasm	9.51e-05	0.00157	CcSEcCtD
Mitomycin—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	9.49e-05	0.00156	CcSEcCtD
Mitomycin—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	9.45e-05	0.00156	CcSEcCtD
Mitomycin—Anaemia—Vincristine—peripheral nervous system neoplasm	9.45e-05	0.00156	CcSEcCtD
Mitomycin—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	9.42e-05	0.00155	CcSEcCtD
Mitomycin—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	9.42e-05	0.00155	CcSEcCtD
Mitomycin—Oedema—Dactinomycin—peripheral nervous system neoplasm	9.34e-05	0.00154	CcSEcCtD
Mitomycin—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	9.33e-05	0.00153	CcSEcCtD
Mitomycin—Cough—Alitretinoin—peripheral nervous system neoplasm	9.26e-05	0.00152	CcSEcCtD
Mitomycin—Alopecia—Cisplatin—peripheral nervous system neoplasm	9.18e-05	0.00151	CcSEcCtD
Mitomycin—Hypertension—Alitretinoin—peripheral nervous system neoplasm	9.16e-05	0.00151	CcSEcCtD
Mitomycin—Leukopenia—Vincristine—peripheral nervous system neoplasm	9.15e-05	0.00151	CcSEcCtD
Mitomycin—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	9.14e-05	0.0015	CcSEcCtD
Mitomycin—Body temperature increased—Topotecan—peripheral nervous system neoplasm	9.11e-05	0.0015	CcSEcCtD
Mitomycin—Erythema—Cisplatin—peripheral nervous system neoplasm	9.04e-05	0.00149	CcSEcCtD
Mitomycin—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	9.03e-05	0.00149	CcSEcCtD
Mitomycin—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	9.03e-05	0.00149	CcSEcCtD
Mitomycin—Discomfort—Alitretinoin—peripheral nervous system neoplasm	8.92e-05	0.00147	CcSEcCtD
Mitomycin—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.00147	CcSEcCtD
Mitomycin—Anorexia—Dactinomycin—peripheral nervous system neoplasm	8.9e-05	0.00147	CcSEcCtD
Mitomycin—Hypertension—Vincristine—peripheral nervous system neoplasm	8.83e-05	0.00145	CcSEcCtD
Mitomycin—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	8.75e-05	0.00144	CcSEcCtD
Mitomycin—Confusional state—Alitretinoin—peripheral nervous system neoplasm	8.73e-05	0.00144	CcSEcCtD
Mitomycin—Oedema—Alitretinoin—peripheral nervous system neoplasm	8.66e-05	0.00143	CcSEcCtD
Mitomycin—Vision blurred—Cisplatin—peripheral nervous system neoplasm	8.52e-05	0.0014	CcSEcCtD
Mitomycin—Shock—Alitretinoin—peripheral nervous system neoplasm	8.52e-05	0.0014	CcSEcCtD
Mitomycin—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	8.5e-05	0.0014	CcSEcCtD
Mitomycin—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	8.48e-05	0.0014	CcSEcCtD
Mitomycin—Alopecia—Etoposide—peripheral nervous system neoplasm	8.41e-05	0.00138	CcSEcCtD
Mitomycin—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	8.39e-05	0.00138	CcSEcCtD
Mitomycin—Anaemia—Cisplatin—peripheral nervous system neoplasm	8.36e-05	0.00138	CcSEcCtD
Mitomycin—Oedema—Vincristine—peripheral nervous system neoplasm	8.34e-05	0.00137	CcSEcCtD
Mitomycin—Asthenia—Topotecan—peripheral nervous system neoplasm	8.26e-05	0.00136	CcSEcCtD
Mitomycin—Anorexia—Alitretinoin—peripheral nervous system neoplasm	8.25e-05	0.00136	CcSEcCtD
Mitomycin—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.00136	CcSEcCtD
Mitomycin—Asthenia—Tretinoin—peripheral nervous system neoplasm	8.2e-05	0.00135	CcSEcCtD
Mitomycin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	8.2e-05	0.00135	CcSEcCtD
Mitomycin—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	8.17e-05	0.00134	CcSEcCtD
Mitomycin—Malaise—Cisplatin—peripheral nervous system neoplasm	8.15e-05	0.00134	CcSEcCtD
Mitomycin—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	8.12e-05	0.00134	CcSEcCtD
Mitomycin—Renal impairment—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.00133	CcSEcCtD
Mitomycin—Leukopenia—Cisplatin—peripheral nervous system neoplasm	8.09e-05	0.00133	CcSEcCtD
Mitomycin—Asthenia—Melphalan—peripheral nervous system neoplasm	8.09e-05	0.00133	CcSEcCtD
Mitomycin—Fatigue—Dactinomycin—peripheral nervous system neoplasm	8.05e-05	0.00133	CcSEcCtD
Mitomycin—Pain—Dactinomycin—peripheral nervous system neoplasm	7.99e-05	0.00131	CcSEcCtD
Mitomycin—Anorexia—Vincristine—peripheral nervous system neoplasm	7.95e-05	0.00131	CcSEcCtD
Mitomycin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	7.88e-05	0.0013	CcSEcCtD
Mitomycin—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.00129	CcSEcCtD
Mitomycin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	7.82e-05	0.00129	CcSEcCtD
Mitomycin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	7.82e-05	0.00129	CcSEcCtD
Mitomycin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	7.72e-05	0.00127	CcSEcCtD
Mitomycin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	7.72e-05	0.00127	CcSEcCtD
Mitomycin—Somnolence—Alitretinoin—peripheral nervous system neoplasm	7.7e-05	0.00127	CcSEcCtD
Mitomycin—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	7.7e-05	0.00127	CcSEcCtD
Mitomycin—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	7.68e-05	0.00126	CcSEcCtD
Mitomycin—Anaemia—Etoposide—peripheral nervous system neoplasm	7.65e-05	0.00126	CcSEcCtD
Mitomycin—Dizziness—Topotecan—peripheral nervous system neoplasm	7.62e-05	0.00125	CcSEcCtD
Mitomycin—Discomfort—Cisplatin—peripheral nervous system neoplasm	7.6e-05	0.00125	CcSEcCtD
Mitomycin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	7.56e-05	0.00124	CcSEcCtD
Mitomycin—Dizziness—Tretinoin—peripheral nervous system neoplasm	7.56e-05	0.00124	CcSEcCtD
Mitomycin—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	7.53e-05	0.00124	CcSEcCtD
Mitomycin—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.00123	CcSEcCtD
Mitomycin—Malaise—Etoposide—peripheral nervous system neoplasm	7.47e-05	0.00123	CcSEcCtD
Mitomycin—Fatigue—Alitretinoin—peripheral nervous system neoplasm	7.47e-05	0.00123	CcSEcCtD
Mitomycin—Leukopenia—Etoposide—peripheral nervous system neoplasm	7.41e-05	0.00122	CcSEcCtD
Mitomycin—Pain—Alitretinoin—peripheral nervous system neoplasm	7.4e-05	0.00122	CcSEcCtD
Mitomycin—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	7.38e-05	0.00122	CcSEcCtD
Mitomycin—Oedema—Cisplatin—peripheral nervous system neoplasm	7.38e-05	0.00121	CcSEcCtD
Mitomycin—Vomiting—Topotecan—peripheral nervous system neoplasm	7.32e-05	0.00121	CcSEcCtD
Mitomycin—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	7.28e-05	0.0012	CcSEcCtD
Mitomycin—Vomiting—Tretinoin—peripheral nervous system neoplasm	7.26e-05	0.0012	CcSEcCtD
Mitomycin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	7.26e-05	0.0012	CcSEcCtD
Mitomycin—Rash—Topotecan—peripheral nervous system neoplasm	7.26e-05	0.0012	CcSEcCtD
Mitomycin—Dermatitis—Topotecan—peripheral nervous system neoplasm	7.26e-05	0.00119	CcSEcCtD
Mitomycin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	7.25e-05	0.00119	CcSEcCtD
Mitomycin—Cough—Etoposide—peripheral nervous system neoplasm	7.23e-05	0.00119	CcSEcCtD
Mitomycin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	7.22e-05	0.00119	CcSEcCtD
Mitomycin—Headache—Topotecan—peripheral nervous system neoplasm	7.22e-05	0.00119	CcSEcCtD
Mitomycin—Rash—Tretinoin—peripheral nervous system neoplasm	7.2e-05	0.00119	CcSEcCtD
Mitomycin—Rash—Isotretinoin—peripheral nervous system neoplasm	7.2e-05	0.00119	CcSEcCtD
Mitomycin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	7.2e-05	0.00118	CcSEcCtD
Mitomycin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	7.2e-05	0.00118	CcSEcCtD
Mitomycin—Fatigue—Vincristine—peripheral nervous system neoplasm	7.19e-05	0.00118	CcSEcCtD
Mitomycin—Vomiting—Melphalan—peripheral nervous system neoplasm	7.17e-05	0.00118	CcSEcCtD
Mitomycin—Headache—Isotretinoin—peripheral nervous system neoplasm	7.16e-05	0.00118	CcSEcCtD
Mitomycin—Headache—Tretinoin—peripheral nervous system neoplasm	7.16e-05	0.00118	CcSEcCtD
Mitomycin—Hypertension—Etoposide—peripheral nervous system neoplasm	7.15e-05	0.00118	CcSEcCtD
Mitomycin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	7.14e-05	0.00117	CcSEcCtD
Mitomycin—Pain—Vincristine—peripheral nervous system neoplasm	7.14e-05	0.00117	CcSEcCtD
Mitomycin—Rash—Melphalan—peripheral nervous system neoplasm	7.11e-05	0.00117	CcSEcCtD
Mitomycin—Dermatitis—Melphalan—peripheral nervous system neoplasm	7.1e-05	0.00117	CcSEcCtD
Mitomycin—Anorexia—Cisplatin—peripheral nervous system neoplasm	7.03e-05	0.00116	CcSEcCtD
Mitomycin—Discomfort—Etoposide—peripheral nervous system neoplasm	6.97e-05	0.00115	CcSEcCtD
Mitomycin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	6.85e-05	0.00113	CcSEcCtD
Mitomycin—Nausea—Topotecan—peripheral nervous system neoplasm	6.84e-05	0.00113	CcSEcCtD
Mitomycin—Confusional state—Etoposide—peripheral nervous system neoplasm	6.82e-05	0.00112	CcSEcCtD
Mitomycin—Nausea—Tretinoin—peripheral nervous system neoplasm	6.79e-05	0.00112	CcSEcCtD
Mitomycin—Nausea—Isotretinoin—peripheral nervous system neoplasm	6.79e-05	0.00112	CcSEcCtD
Mitomycin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	6.7e-05	0.0011	CcSEcCtD
Mitomycin—Nausea—Melphalan—peripheral nervous system neoplasm	6.7e-05	0.0011	CcSEcCtD
Mitomycin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	6.62e-05	0.00109	CcSEcCtD
Mitomycin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	6.6e-05	0.00109	CcSEcCtD
Mitomycin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	6.58e-05	0.00108	CcSEcCtD
Mitomycin—Anorexia—Etoposide—peripheral nervous system neoplasm	6.44e-05	0.00106	CcSEcCtD
Mitomycin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	6.41e-05	0.00106	CcSEcCtD
Mitomycin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	6.39e-05	0.00105	CcSEcCtD
Mitomycin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.00104	CcSEcCtD
Mitomycin—Pain—Cisplatin—peripheral nervous system neoplasm	6.31e-05	0.00104	CcSEcCtD
Mitomycin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	6.21e-05	0.00102	CcSEcCtD
Mitomycin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	6.08e-05	0.001	CcSEcCtD
Mitomycin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	6.03e-05	0.000992	CcSEcCtD
Mitomycin—Somnolence—Etoposide—peripheral nervous system neoplasm	6.01e-05	0.000989	CcSEcCtD
Mitomycin—Asthenia—Vincristine—peripheral nervous system neoplasm	5.99e-05	0.000985	CcSEcCtD
Mitomycin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000978	CcSEcCtD
Mitomycin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	5.94e-05	0.000977	CcSEcCtD
Mitomycin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.92e-05	0.000975	CcSEcCtD
Mitomycin—Rash—Dactinomycin—peripheral nervous system neoplasm	5.89e-05	0.000969	CcSEcCtD
Mitomycin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.88e-05	0.000967	CcSEcCtD
Mitomycin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000964	CcSEcCtD
Mitomycin—Renal failure—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.000961	CcSEcCtD
Mitomycin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.83e-05	0.00096	CcSEcCtD
Mitomycin—Fatigue—Etoposide—peripheral nervous system neoplasm	5.83e-05	0.000959	CcSEcCtD
Mitomycin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000953	CcSEcCtD
Mitomycin—Pain—Etoposide—peripheral nervous system neoplasm	5.78e-05	0.000951	CcSEcCtD
Mitomycin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	5.73e-05	0.000942	CcSEcCtD
Mitomycin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	5.71e-05	0.00094	CcSEcCtD
Mitomycin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	5.57e-05	0.000917	CcSEcCtD
Mitomycin—Nausea—Dactinomycin—peripheral nervous system neoplasm	5.55e-05	0.000913	CcSEcCtD
Mitomycin—Dizziness—Vincristine—peripheral nervous system neoplasm	5.52e-05	0.000908	CcSEcCtD
Mitomycin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.51e-05	0.000906	CcSEcCtD
Mitomycin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000905	CcSEcCtD
Mitomycin—Rash—Alitretinoin—peripheral nervous system neoplasm	5.46e-05	0.000899	CcSEcCtD
Mitomycin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.45e-05	0.000898	CcSEcCtD
Mitomycin—Headache—Alitretinoin—peripheral nervous system neoplasm	5.42e-05	0.000893	CcSEcCtD
Mitomycin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000889	CcSEcCtD
Mitomycin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000882	CcSEcCtD
Mitomycin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5.34e-05	0.000879	CcSEcCtD
Mitomycin—Vomiting—Vincristine—peripheral nervous system neoplasm	5.31e-05	0.000873	CcSEcCtD
Mitomycin—Asthenia—Cisplatin—peripheral nervous system neoplasm	5.29e-05	0.000871	CcSEcCtD
Mitomycin—Rash—Vincristine—peripheral nervous system neoplasm	5.26e-05	0.000866	CcSEcCtD
Mitomycin—Dermatitis—Vincristine—peripheral nervous system neoplasm	5.26e-05	0.000865	CcSEcCtD
Mitomycin—Headache—Vincristine—peripheral nervous system neoplasm	5.23e-05	0.00086	CcSEcCtD
Mitomycin—Nausea—Alitretinoin—peripheral nervous system neoplasm	5.14e-05	0.000847	CcSEcCtD
Mitomycin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	5.05e-05	0.000831	CcSEcCtD
Mitomycin—Nausea—Vincristine—peripheral nervous system neoplasm	4.96e-05	0.000816	CcSEcCtD
Mitomycin—Asthenia—Etoposide—peripheral nervous system neoplasm	4.85e-05	0.000798	CcSEcCtD
Mitomycin—Alopecia—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000776	CcSEcCtD
Mitomycin—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.69e-05	0.000772	CcSEcCtD
Mitomycin—Rash—Cisplatin—peripheral nervous system neoplasm	4.65e-05	0.000766	CcSEcCtD
Mitomycin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.65e-05	0.000765	CcSEcCtD
Mitomycin—Erythema—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000764	CcSEcCtD
Mitomycin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.62e-05	0.000761	CcSEcCtD
Mitomycin—Dizziness—Etoposide—peripheral nervous system neoplasm	4.47e-05	0.000736	CcSEcCtD
Mitomycin—Nausea—Cisplatin—peripheral nervous system neoplasm	4.38e-05	0.000721	CcSEcCtD
Mitomycin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	4.38e-05	0.00072	CcSEcCtD
Mitomycin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	0.000718	CcSEcCtD
Mitomycin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000709	CcSEcCtD
Mitomycin—Vomiting—Etoposide—peripheral nervous system neoplasm	4.3e-05	0.000707	CcSEcCtD
Mitomycin—Erythema—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	0.000707	CcSEcCtD
Mitomycin—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.000706	CcSEcCtD
Mitomycin—Rash—Etoposide—peripheral nervous system neoplasm	4.26e-05	0.000701	CcSEcCtD
Mitomycin—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.26e-05	0.000701	CcSEcCtD
Mitomycin—Headache—Etoposide—peripheral nervous system neoplasm	4.23e-05	0.000697	CcSEcCtD
Mitomycin—Malaise—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000689	CcSEcCtD
Mitomycin—Syncope—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000685	CcSEcCtD
Mitomycin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000684	CcSEcCtD
Mitomycin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	4.08e-05	0.000672	CcSEcCtD
Mitomycin—Cough—Epirubicin—peripheral nervous system neoplasm	4.05e-05	0.000667	CcSEcCtD
Mitomycin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000666	CcSEcCtD
Mitomycin—Nausea—Etoposide—peripheral nervous system neoplasm	4.01e-05	0.000661	CcSEcCtD
Mitomycin—Hypertension—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.00066	CcSEcCtD
Mitomycin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000656	CcSEcCtD
Mitomycin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000653	CcSEcCtD
Mitomycin—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000643	CcSEcCtD
Mitomycin—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000638	CcSEcCtD
Mitomycin—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000634	CcSEcCtD
Mitomycin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000633	CcSEcCtD
Mitomycin—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.82e-05	0.000629	CcSEcCtD
Mitomycin—Oedema—Epirubicin—peripheral nervous system neoplasm	3.79e-05	0.000624	CcSEcCtD
Mitomycin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.78e-05	0.000621	CcSEcCtD
Mitomycin—Cough—Doxorubicin—peripheral nervous system neoplasm	3.75e-05	0.000617	CcSEcCtD
Mitomycin—Shock—Epirubicin—peripheral nervous system neoplasm	3.73e-05	0.000613	CcSEcCtD
Mitomycin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.71e-05	0.000611	CcSEcCtD
Mitomycin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.00061	CcSEcCtD
Mitomycin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000595	CcSEcCtD
Mitomycin—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000594	CcSEcCtD
Mitomycin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.53e-05	0.000582	CcSEcCtD
Mitomycin—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.51e-05	0.000577	CcSEcCtD
Mitomycin—Shock—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.000568	CcSEcCtD
Mitomycin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.43e-05	0.000565	CcSEcCtD
Mitomycin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000556	CcSEcCtD
Mitomycin—Somnolence—Epirubicin—peripheral nervous system neoplasm	3.37e-05	0.000554	CcSEcCtD
Mitomycin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.00055	CcSEcCtD
Mitomycin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000542	CcSEcCtD
Mitomycin—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000538	CcSEcCtD
Mitomycin—Pain—Epirubicin—peripheral nervous system neoplasm	3.24e-05	0.000533	CcSEcCtD
Mitomycin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000514	CcSEcCtD
Mitomycin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000514	CcSEcCtD
Mitomycin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.12e-05	0.000513	CcSEcCtD
Mitomycin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000502	CcSEcCtD
Mitomycin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000497	CcSEcCtD
Mitomycin—Pain—Doxorubicin—peripheral nervous system neoplasm	3e-05	0.000493	CcSEcCtD
Mitomycin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3e-05	0.000493	CcSEcCtD
Mitomycin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000475	CcSEcCtD
Mitomycin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.000456	CcSEcCtD
Mitomycin—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.72e-05	0.000447	CcSEcCtD
Mitomycin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.59e-05	0.000427	CcSEcCtD
Mitomycin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.52e-05	0.000414	CcSEcCtD
Mitomycin—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.51e-05	0.000412	CcSEcCtD
Mitomycin—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.41e-05	0.000396	CcSEcCtD
Mitomycin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000395	CcSEcCtD
Mitomycin—Rash—Epirubicin—peripheral nervous system neoplasm	2.39e-05	0.000393	CcSEcCtD
Mitomycin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.39e-05	0.000393	CcSEcCtD
Mitomycin—Headache—Epirubicin—peripheral nervous system neoplasm	2.37e-05	0.000391	CcSEcCtD
Mitomycin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.32e-05	0.000382	CcSEcCtD
Mitomycin—Nausea—Epirubicin—peripheral nervous system neoplasm	2.25e-05	0.00037	CcSEcCtD
Mitomycin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.23e-05	0.000367	CcSEcCtD
Mitomycin—Rash—Doxorubicin—peripheral nervous system neoplasm	2.21e-05	0.000364	CcSEcCtD
Mitomycin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.21e-05	0.000363	CcSEcCtD
Mitomycin—Headache—Doxorubicin—peripheral nervous system neoplasm	2.2e-05	0.000361	CcSEcCtD
Mitomycin—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.08e-05	0.000343	CcSEcCtD
